Replimune Statistics Share Statistics Replimune has 78.06M
shares outstanding. The number of shares has increased by 3.6%
in one year.
Shares Outstanding 78.06M Shares Change (YoY) 3.6% Shares Change (QoQ) 1.26% Owned by Institutions (%) 84.83% Shares Floating 64.02M Failed to Deliver (FTD) Shares 704 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 17.28M, so 22.13% of the outstanding
shares have been sold short.
Short Interest 17.28M Short % of Shares Out 22.13% Short % of Float 41.57% Short Ratio (days to cover) 7.06
Valuation Ratios The PE ratio is -3.18 and the forward
PE ratio is -1.6.
Replimune's PEG ratio is
0.61.
PE Ratio -3.18 Forward PE -1.6 PS Ratio 0 Forward PS 70.3 PB Ratio 1.89 P/FCF Ratio -3.95 PEG Ratio 0.61
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Replimune.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.95,
with a Debt / Equity ratio of 0.18.
Current Ratio 7.95 Quick Ratio 7.95 Debt / Equity 0.18 Debt / EBITDA -0.29 Debt / FCF -0.38 Interest Coverage -33.15
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-516.28K Employee Count 479 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 468K Effective Tax Rate -0.19%
Stock Price Statistics The stock price has increased by -59.08% in the
last 52 weeks. The beta is 0.42, so Replimune's
price volatility has been higher than the market average.
Beta 0.42 52-Week Price Change -59.08% 50-Day Moving Average 5.22 200-Day Moving Average 9.2 Relative Strength Index (RSI) 48.03 Average Volume (20 Days) 10,149,658
Income Statement
Revenue n/a Gross Profit -3.5M Operating Income -261.63M Net Income -247.3M EBITDA -261.63M EBIT -240.71M Earnings Per Share (EPS) -3.07
Full Income Statement Balance Sheet The company has 111.12M in cash and 76.17M in
debt, giving a net cash position of 34.95M.
Cash & Cash Equivalents 111.12M Total Debt 76.17M Net Cash 34.95M Retained Earnings -948.58M Total Assets 469.51M Working Capital 353.81M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -192.25M
and capital expenditures -6.69M, giving a free cash flow of -198.94M.
Operating Cash Flow -192.25M Capital Expenditures -6.69M Free Cash Flow -198.94M FCF Per Share -2.47
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
